TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from BCAL Diagnostics Limited ( (AU:BDX) ).
BCAL Diagnostics Limited has announced its Annual General Meeting scheduled for November 28, 2025, at Gadens in Sydney, with an option to attend online. The meeting will address several key resolutions, including the approval of the remuneration report and the re-election of director Jonathan Trollip. Shareholders are encouraged to participate and vote, either in person or by proxy, on these resolutions, which are crucial for the company’s governance and strategic direction.
More about BCAL Diagnostics Limited
BCAL Diagnostics Limited is a company operating in the healthcare industry, focusing on diagnostic solutions. The company is involved in the development and commercialization of innovative diagnostic technologies.
Average Trading Volume: 382,592
Technical Sentiment Signal: Buy
Current Market Cap: A$32.94M
For a thorough assessment of BDX stock, go to TipRanks’ Stock Analysis page.